Glyra Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Glyra Pharmaceuticals Private Limited

Glyra Pharmaceuticals Private Limited, a struck off private limited company, was established on 31 July 2017 in Hyderabad, Telangana, India. Engaging in wholesale within the trading sector, it holds CIN: U51909TG2017PTC118628. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.80 M.

It upholds a active non-compliant status. Its leadership includes Ansarul Haque Seikh (Director), Malik Basha Syed (Director), Bharath Kumar Kammari (Director). It is based at H.No. 16-11-16/A/80 Afzal Nagar, Malakpet, Hyderabad, Telangana, 500036.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909TG2017PTC118628

  • Registration Number

    118628

  • Incorporation Date

    31 July 2017

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.80 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.80 M
  • Company Age 8 Year, 9 Months
Company report

Glyra Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Glyra Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Glyra Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ansarul Haque Seikh Director 31 Jul 2017 Current
Malik Basha Syed Director 31 Jul 2017 Current
Bharath Kumar Kammari Director 31 Jul 2017 Current
Shaik Mohammed Basheer Ahammed Director 31 Jul 2017 Current
Mohammad Rafeeq Director 31 Jul 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glyra Pharmaceuticals.

Enhance accessibility to Glyra Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Glyra Pharmaceuticals revenue growth over time
Glyra Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glyra Pharmaceuticals?

Unlock access to Glyra Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Glyra Pharmaceuticals?

Unlock and access historical data on people associated with Glyra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glyra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glyra Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glyra Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Ansarul Haque Seikh was appointed as a Director was appointed as a Director on 31 Jul 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Malik Basha Syed was appointed as a Director was appointed as a Director on 31 Jul 2017 & has been associated with this company since 8 years 9 months . was completed.

  • Director Appointment

    Progress on Bharath Kumar Kammari was appointed as a Director was appointed as a Director on 31 Jul 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Director Appointment

    Progress on Shaik Mohammed Basheer Ahammed was appointed as a Director was appointed as a Director on 31 Jul 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Director Appointment

    Progress on Mohammad Rafeeq was appointed as a Director was appointed as a Director on 31 Jul 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Company Incorporation

    Progress on Glyra Pharmaceuticals Private Limited was registered on 31 Jul 2017 with Roc Hyderabad & aged 8 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Glyra Pharmaceuticals Private Limited?

The CIN of Glyra Pharmaceuticals Private Limited is U51909TG2017PTC118628.

Where is Glyra Pharmaceuticals Private Limited headquartered?

Glyra Pharmaceuticals Private Limited is headquartered at H.No. 16-11-16/A/80 Afzal Nagar, Malakpet, Hyderabad, Telangana, 500036.

When was Glyra Pharmaceuticals Private Limited incorporated?

Glyra Pharmaceuticals Private Limited was incorporated on 31 July 2017.

Who are the current directors of Glyra Pharmaceuticals Private Limited?

The current directors of Glyra Pharmaceuticals Private Limited are

What is the primary industry of Glyra Pharmaceuticals Private Limited?

The primary industry of Glyra Pharmaceuticals Private Limited is Trading.

Is Glyra Pharmaceuticals Private Limited a listed company?

Glyra Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Glyra Pharmaceuticals Private Limited?

The authorized capital of Glyra Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.80 M.

What is the compliance status of Glyra Pharmaceuticals Private Limited?

The compliance status of Glyra Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available